William F. Pendergraft, Ph.D. - Publications

Affiliations: 
2003 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Immunology, Pathology, Cell Biology

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, ... ... Pendergraft WF, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nature Immunology. PMID 31209404 DOI: 10.1038/S41590-019-0398-X  0.371
2018 McCall AS, Bhave G, Pedchenko V, Hess J, Free M, Little DJ, Baker TP, Pendergraft WF, Falk RJ, Olson SW, Hudson BG. Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes. Journal of the American Society of Nephrology : Jasn. PMID 30279272 DOI: 10.1681/Asn.2018050519  0.688
2017 Brown LC, Jobson MA, Payan Schober F, Chang EH, Falk RJ, Nachman PH, Pendergraft WF. The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy. American Journal of Nephrology. 45: 365-372. PMID 28315862 DOI: 10.1159/000464475  0.441
2016 Cortazar FB, Pendergraft WF, Wenger J, Owens CT, Laliberte K, Niles JL. The effect of continuous B cell depletion with rituximab on pathogenic autoantibodies and total IgG levels in ANCA vasculitis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28029751 DOI: 10.1002/Art.40032  0.32
2016 Jones BE, Yang J, Muthigi A, Hogan SL, Hu Y, Starmer J, Henderson CD, Poulton CJ, Brant EJ, Pendergraft WF, Jennette JC, Falk RJ, Ciavatta DJ. Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis. Journal of the American Society of Nephrology : Jasn. PMID 27821628 DOI: 10.1681/Asn.2016050548  0.488
2016 Yang J, Ge H, Poulton CJ, Hogan SL, Hu Y, Jones BE, Henderson CD, McInnis EA, Pendergraft WF, Jennette JC, Falk RJ, Ciavatta DJ. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Clinical Epigenetics. 8: 85. PMID 27752292 DOI: 10.1186/S13148-016-0251-0  0.532
2015 Jobson MA, Hogan SL, Maxwell CS, Hu Y, Hladik GA, Falk RJ, Beuhler MC, Pendergraft WF. Clinical Features of Reported Ethylene Glycol Exposures in the United States. Plos One. 10: e0143044. PMID 26566024 DOI: 10.1371/Journal.Pone.0143044  0.476
2015 Pendergraft WF, Nachman PH. Recent pathogenetic advances in ANCA-associated vasculitis. Presse MéDicale (Paris, France : 1983). 44: e223-9. PMID 26033562 DOI: 10.1016/J.Lpm.2015.04.007  0.369
2015 Bunch DO, Mendoza CE, Aybar LT, Kotzen ES, Colby KR, Hu Y, Hogan SL, Poulton CJ, Schmitz JL, Falk RJ, Nachman PH, Pendergraft WF, McGregor JG. Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis. Annals of the Rheumatic Diseases. PMID 25934841 DOI: 10.1136/Annrheumdis-2014-206756  0.505
2015 Schober FP, Pendergraft WF. Dialogue: A blissful future for lupus nephritis: harnessing repeat kidney biopsies to identify meaningful biomarkers of disease. Lupus Science & Medicine. 2: e000083. PMID 25866670 DOI: 10.1136/Lupus-2015-000083  0.359
2015 Pendergraft WF, Badhwar AK, Preston GA. Autoantigen complementarity and its contributions to hallmarks of autoimmune disease. Journal of Theoretical Biology. 375: 88-94. PMID 25526886 DOI: 10.1016/J.Jtbi.2014.12.006  0.332
2015 Pendergraft WF, Falk RJ. Understanding the role of rituximab in ANCA GN: regressing toward the mean. Journal of the American Society of Nephrology : Jasn. 26: 771-4. PMID 25381425 DOI: 10.1681/Asn.2014100997  0.52
2014 Pendergraft WF, Niles JL. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Current Opinion in Rheumatology. 26: 42-9. PMID 24276086 DOI: 10.1097/Bor.0000000000000014  0.301
2013 Ramirez-Ortiz ZG, Pendergraft WF, Prasad A, Byrne MH, Iram T, Blanchette CJ, Luster AD, Hacohen N, El Khoury J, Means TK. The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nature Immunology. 14: 917-26. PMID 23892722 DOI: 10.1038/Ni.2670  0.35
2010 Ciavatta DJ, Yang J, Preston GA, Badhwar AK, Xiao H, Hewins P, Nester CM, Pendergraft WF, Magnuson TR, Jennette JC, Falk RJ. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis Journal of Clinical Investigation. 120: 3209-3219. PMID 20714105 DOI: 10.1172/Jci40034  0.51
2007 Farrag L, Pendergraft WF, Yang JJ, Jennette JC, Falk RJ, Preston GA. A study of conformational restraints on reactivity of human PR3-specific autoantibodies (ANCA) facilitated through protein folding manipulations of a new recombinant proteinase 3 protein. Autoimmunity. 40: 503-11. PMID 17966040 DOI: 10.1080/08916930701680104  0.51
2007 Astern JM, Pendergraft WF, Falk RJ, Jennette JC, Schmaier AH, Mahdi F, Preston GA. Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system. The American Journal of Pathology. 171: 349-60. PMID 17591979 DOI: 10.2353/Ajpath.2007.060831  0.664
2005 Preston GA, Pendergraft WF, Falk RJ. New insights that link microbes with the generation of antineutrophil cytoplasmic autoantibodies: the theory of autoantigen complementarity. Current Opinion in Nephrology and Hypertension. 14: 217-22. PMID 15821413 DOI: 10.1097/01.Mnh.0000165886.93427.B1  0.507
2005 Pendergraft WF, Pressler BM, Jennette JC, Falk RJ, Preston GA. Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease. Journal of Molecular Medicine (Berlin, Germany). 83: 12-25. PMID 15592920 DOI: 10.1007/S00109-004-0615-3  0.532
2004 Yang JJ, Pendergraft WF, Alcorta DA, Nachman PH, Hogan SL, Thomas RP, Sullivan P, Jennette JC, Falk RJ, Preston GA. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Journal of the American Society of Nephrology : Jasn. 15: 2103-14. PMID 15284296 DOI: 10.1097/01.Asn.0000135058.46193.72  0.545
2004 Pendergraft WF, Rudolph EH, Falk RJ, Jahn JE, Grimmler M, Hengst L, Jennette JC, Preston GA. Proteinase 3 sidesteps caspases and cleaves p21(Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis. Kidney International. 65: 75-84. PMID 14675038 DOI: 10.1111/J.1523-1755.2004.00364.X  0.515
2004 Pendergraft WF, Preston GA, Shah RR, Tropsha A, Carter CW, Jennette JC, Falk RJ. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nature Medicine. 10: 72-9. PMID 14661018 DOI: 10.1038/Nm968  0.518
2002 Preston GA, Zarella CS, Pendergraft WF, Rudolph EH, Yang JJ, Sekura SB, Jennette JC, Falk RJ. Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. Journal of the American Society of Nephrology : Jasn. 13: 2840-9. PMID 12444202 DOI: 10.1097/01.Asn.0000034911.03334.C3  0.526
2001 Yang JJ, Preston GA, Pendergraft WF, Segelmark M, Heeringa P, Hogan SL, Jennette JC, Falk RJ. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. The American Journal of Pathology. 158: 581-92. PMID 11159195 DOI: 10.1016/S0002-9440(10)64000-X  0.561
2000 Pendergraft WF, Alcorta DA, Segelmark M, Yang JJ, Tuttle R, Jennette JC, Falk RJ, Preston GA. ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells. Kidney International. 57: 1981-90. PMID 10792617 DOI: 10.1046/J.1523-1755.2000.00048.X  0.535
2000 Segelmark M, Barrett C, Pendergraft W, Falk R, Preston G. Expression of p300-truncated fragments results in the modulation of apoptosis in rat mesangial cells. Kidney International. 57: 1873-81. PMID 10792606 DOI: 10.1046/J.1523-1755.2000.00037.X  0.452
Show low-probability matches.